Publikace
- Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition2024 | Přírodovědecká fakulta, 1. lékařská fakulta, 3. lékařská fakulta
- Structure-Guided Design of N-Methylpropargylamino- Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's Disease2023 | Farmaceutická fakulta v Hradci Králové, Přírodovědecká fakulta
- UHPLC-Orbitrap study of the first phase tacrine in vitro metabolites and related Alzheimer's drug candidates using human liver microsomes2023 | Farmaceutická fakulta v Hradci Králové
- Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation2023 | Farmaceutická fakulta v Hradci Králové
- Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonists2021 | Farmaceutická fakulta v Hradci Králové, Přírodovědecká fakulta
- Huprine Y-Tryptophan heterodimers with potential implication to Alzheimer's disease treatment2021 | Farmaceutická fakulta v Hradci Králové, 1. lékařská fakulta
- Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study2021 | Farmaceutická fakulta v Hradci Králové
- Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease2021 | Publikace bez příslušnosti k fakultě
- Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease2021 | Publikace bez příslušnosti k fakultě
- Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties2021 | Publikace bez příslušnosti k fakultě
Loading network view...